Gabelli Asset ETF GAST 深 滬
已收盤 12-12 16:00:00 美东时间
32.2791
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 32.2791
- 總市值 645.58万
- 52周最高 33.637
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 22.3524
- 委 比 0.00%
- 總股本 20.00万
- 歷史最高 33.637
- 量 比 0
- 振 幅 0.00%
- 歷史最低 18.2622
- 每 手 1
- 風險率 2.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多华盛早报 | 英伟达、甲骨文、AMD只是开始？OpenAI还有大交易！“IPO超购王”金叶国际今日上市
英伟达、甲骨文、AMD只是开始？OpenAI还有大交易！“IPO超购王”金叶国际今日上市，暗盘一度暴涨880%；谁是下一任美联储主席？这4个人最有希望>>
2025-10-10 08:25
一周IPO | 梦回2020年港股打新牛市！宁德时代首日涨超16%；手回集团招股中
梦回2020年港股打新牛市！恒瑞医药首日飙升25%，宁德时代首日涨超16%；"小雨伞保险经纪母公司"手回集团招股中；派格生物医药、吉宏股份等预计下周上市>>
2025-05-23 18:28
一周IPO | 恒瑞医药折价逾20%冲刺港股！宁德时代认购火爆，发售价定为每股H股263港元
宁德时代认购火爆！发售价定为每股H股263港元；恒瑞医药折价逾20%冲刺港股，孖展认购约30倍；Antalpha美股IPO首日飙涨27%>>
2025-05-16 20:58
一周财经日历丨今年全球最大IPO！宁德时代下周二登陆港股；黄仁勋再登国际电脑展
今年全球最大IPO！宁德时代下周二登陆港股；黄仁勋再登国际电脑展，AI合作新动向成全场焦点；百度、小鹏、B站等财报重磅来袭；多位美联储官员发表讲话>>
2025-05-17 14:42
BRIEF-Merck And Eisai Provide Update On Phase 3 Leap-015 Trial
Jan 24 (Reuters) - Merck & Co Inc MRK.N: MERCK AND EISAI PROVIDE UPDATE ON PHASE 3 LEAP-015 TRIAL EVALUATING KEYTRUDA® (PEMBROLIZUMAB) PLUS LENVIMA® (LENVATINIB) IN COMBINATION WITH CHEMOTHERAPY IN PA...
2025-01-24 20:26
BRIEF-Alx Oncology Presents Positive Updated Data From Aspen-06 Phase 2 Trial
Jan 23 (Reuters) - ALX Oncology Holdings Inc ALXO.O: ALX ONCOLOGY PRESENTS POSITIVE UPDATED DATA FROM ASPEN-06 PHASE 2 TRIAL DEMONSTRATING EVORPACEPT GENERATES STRONG RESPONSE AND DURABLE CLINICAL BEN...
2025-01-23 21:09
BRIEF-Simulations Plus And Enabling Technologies Consortium Announce Collaboration
Jan 22 (Reuters) - Simulations Plus Inc SLP.O: SIMULATIONS PLUS AND ENABLING TECHNOLOGIES CONSORTIUM ANNOUNCE STRATEGIC COLLABORATION TO ADVANCE GASTROPLUS® ENHANCEMENTS Source text: ID:nBwXTMPQa Furt...
2025-01-22 20:54
BRIEF-Arrivent Biopharma Enters Exclusive License With Lepu Biopharma For Mrg007, An Antibody Drug Conjugate
Jan 21 (Reuters) - Lepu Biopharma Co Ltd 2157.HK: ENTERS EXCLUSIVE LICENSE WITH LEPU BIOPHARMA FOR MRG007, AN ANTIBODY DRUG CONJUGATE FOR THE TREATMENT OF GASTROINTESTINAL CANCERS Source text: ID:nGNX...
2025-01-22 08:02
BRIEF-Qiagen Secures U.S. Clearance For First Qiastat-Dx Mini Gastrointestinal Panel To Support Year-Round Outpatient Care
Jan 9 (Reuters) - Qiagen NV QIA.DE: QIAGEN SECURES U.S. CLEARANCE FOR FIRST QIASTAT-DX MINI GASTROINTESTINAL PANEL TO SUPPORT YEAR-ROUND OUTPATIENT CARE Source text: ID:nBwSdrfha Further company cover...
2025-01-10 05:09
BRIEF-Geneoscopy Closes $105M In Series C Funding Round
Jan 8 (Reuters) - Geneoscopy : GENEOSCOPY CLOSES $105M IN SERIES C FUNDING ROUND TO POWER NEXT-GENERATION OF GASTROINTESTINAL DIAGNOSTIC TESTS GENEOSCOPY: BIO-RAD LABORATORIES LED FINANCING, JOINED BY...
2025-01-08 22:13
